Clinical Trial Update: An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing VSJ-110 to placebo to evaluate safety and efficacy in treating dry eye, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• VSJ-110

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Dry Eye | Phase 2 | Status: RECRUITING